Research in Gastrointestinal Oncology

The Gastrointestinal (GI) Oncology Program at Weill Cornell Medicine focuses on the care of patients across the entire spectrum of cancers of the digestive system. Our comprehensive and personalized treatment approach optimizes the care a patient receives by offering access to the latest drugs, clinical trials, and state-of-the-art treatment strategies.
Patients with cancers of the GI tract often require expertise across a broad range of disciplines. We are committed to providing personalized and coordinated care in an effort to maximize patient outcomes while minimizing potential side effects of therapy.  We integrate patient care and cutting-edge research with the goal of achieving exceptional diagnostic and therapeutic results. This approach often allows patients to receive treatments not available elsewhere.
The GI Oncology Program at WCM also strongly believes in treating patients as individuals.
We meet the unique needs of each of our patients by tailoring their treatment to their circumstances.

Our team of international and world-renowned oncology specialists is known for advanced work and published research in the esophagus and gastroesophageal cancers, pancreatic cancers, stomach (gastric) cancers, colon cancers, rectal and anal cancers, liver cancers, gallbladder cancers, cancers of the small intestine, and sarcomas, including GIST.
We provide multidisciplinary care with world-class surgical oncologists, gastroenterologists, radiation oncologists, and interventional radiologists.
We also offer precision medicine to provide individualized cancer treatment based on specific genetic vulnerabilities of an individual’s tumor.

Patients receive individualized treatment, combining the best available current knowledge with the latest scientific breakthroughs. We offer patients the most advanced diagnostic methods and a full range of treatment therapies, including surgery, radiation therapy, chemotherapy, immunotherapy or combination treatment methods.

Our patients have access to many multi-phase clinical trials. As active members of the international cancer research community, our oncologists collaborate with other research centers to offer patients the most promising treatments available.

We provide a personalized treatment approach for all of our patients—whether they are newly or previously diagnosed—often involving the newest therapeutic options and state-of-the-art treatment modalities.
We believe in a collaborative approach to provide supportive, comprehensive care, and this enables patients to receive the best possible treatment. We have regular treatment planning meetings with the rest of the GI Oncology group to ensure that patients have the benefit of every physician’s opinion and thought processes.
The Weill Cornell Medicine GI Oncology Program strives to provide the best possible care for all patients during the course of their journey.